Next Post

Moderna booster candidate shows strong response against Omicron subvariants

June 22 (Reuters) – Moderna Inc (MRNA.O) said on Wednesday that an up to date model of its COVID-19 vaccine designed to concentrate on the Omicron variant also generated a strong immune response in opposition to the rapid-spreading Omicron subvariants BA.4 and BA.5, which have attained a foothold in the […]